TRIM25 and ovarian neoplasm: It is reported that ovarian tumor (OTU) domains of CCHFV and HAZV interfere with host innate immune system via the ubiquitin protease activity [42,43] and HAZV N protein interferes with the binding of TRIM25 to RIG-I and subsequent activation of RIG-I [44].